Research

 

Sigma-Tau Pharmaceuticals, Inc. Newsroom

The Sigma-Tau Newsroom is the single location to learn latest developments about the company, its research, as well as important discoveries in the understanding and treatment of rare diseases.
September 30, 2011
Greg On Oncaspar Sigma-Tau Pharmaceuticals announces new pricing for Oncaspar after $50 million effort to avert drug shortage
September 1, 2011 Transition of Matulane® (procarbazine hydrochloride) Distribution
July 28, 2011 Soligenix and Sigma Tau Announce Expansion of Partnership for orBec® in Europe
July 1, 2011 Sigma-Tau Pharmaceuticals, Inc. Announces Addition of VP of Finance
June 27, 2011 Sigma-Tau Pharmaceuticals Announces Co-Pay Program for Oncaspar® (pegaspargase)
June 06, 2011 Claudio Cavazza (Bologna, 4 May 1934), founder and President of Sigma-Tau Group died today in Rome
April 18, 2011 Sigma-Tau Pharmaceuticals announces approval for new manufacturing process for Oncaspar® (pegaspargase) primary ingredient
February 25, 2011
Greg On Rare Diseases Gregg Lapointe, CEO, Sigma-Tau Pharmaceuticals, Inc. on Rare Diseases (a video)
February 22, 2011 Sigma-Tau Pharmaceuticals, Inc. to Join Millions Around the World to Observe Rare Disease Day
August 16, 2010 VSL#3 Probiotic Shown Effective in Dietary Management of Children with IBS
May 17, 2010 Sigma-Tau Pharmaceuticals Cysteamine Eye Drop NDA Accepted for Filing
February 19, 2010 Sigma-Tau Pharmaceuticals, Inc. to Observe Rare Disease Day
November 9, 2009 Sigma-Tau Group to Aquire Enzon Specialty Pharmaceutical Business
October 23, 2009 Sigma-Tau Pharmaceuticals named "Great Place to Work"
April 7, 2009 Sigma-Tau Pharmaceuticals and Danisco Bioactive Announce Partnership Agreement to Develop Drug Candidate for Prevention of Necrotizing Enterocolitis
February 12, 2009 DOR BioPharma and Sigma-Tau Pharmaceuticals Announce Partnership Agreement to Develop New Treatment for Graft Versus Host Disease
January 30, 2009 Sigma-Tau Pharmaceuticals Completes Acquisition of Chenix® (chenodeoxycholic acid) from Solvay Pharmaceuticals, Inc.
January 30, 2009 Sigma-Tau Pharmaceuticals, Inc. to Observe Rare Disease Day with Millions Around the World
July 22, 2008 Sigma-Tau Pharmaceuticals, Inc. Supports PhRMA's Code on Interactions with Healthcare Professionals
July 9, 2008 Sigma-Tau Pharmaceuticals, Inc. Announces Aquisition of Chenofalk
April 22, 2008 Sigma-Tau Pharmaceuticals, Inc. Welcomes Taha Keilani, M.D. as Vice President of Clinical Development
April 22, 2008 European Commission Grants Orphan-Drug Designation for Artesunate for the Immediate Treatment of Malaria
June 22, 2007 FDA Approves Carnitor SF (Levocarnitine) Sugar-Free Oral Solution For Patients With Carnitine Deficiency
March 19, 2007 Walter Reed Army Institute of Research, U.S. Army Medical Materiel Development Activity, and Sigma-Tau Pharmaceuticals, Inc. Announce Collaboration to Investigate New Treatment for Severe Malaria
January 15, 2007 Brian Schreiber, M.D. joins Sigma-Tau Pharmaceuticals, Inc. as Vice President of Medical Affairs
January 04, 2007 DOR BioPharma Receives $3 Million From Sigma-Tau Pharmaceuticals for Exclusive Right to Negotiate orBec(R) Strategic Alliance
March 30, 2006 Sigma-Tau strengthens with Banca Intesa (.pdf)